Search Results - Schwartzberg, L.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer

    An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer by Vacirca, J., Chan, Arlene, Mezei, K., Adoo, C., Pápai, Z., Mcgregor, K., Okera, M., Horváth, Z., Landherr, L., Hanslik, J., Hager, S., Ibrahim, E., Rostom, M., Bhat, G., Choi, M., Reddy, G., Tedesco, K., Agajanian, R., Láng, I., Schwartzberg, L.

    Published 2018
    Get full text
  2. 2
    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast C... by Baselga, J., Zamagni, C., Gómez, P., Bermejo, B., Nagai, S., Melichar, B., Chan, Arlene, Mángel, L., Bergh, J., Costa, F., Gómez, H., Gradishar, W., Hudis, C., Rapoport, B., Roché, H., Patricia, M., Huang, L., Meinhardt, G., Zhang, J., Schwartzberg, L.

    Published 2017
    Get full text

Search Tools: